Showing results (1-10 of 1,016) with videos related to
Sort By:
Pageof 102
Sexually Transmitted Infections|May 4, 2007
Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modellingCatherine M Crespi, William G Cumberland, Anna Wald, et al.Biometrics|March 2, 2005
A queueing model for chronic recurrent conditions under panel observationCatherine M Crespi, William G Cumberland, Sally BlowerThe Journal of Infectious Diseases|October 13, 2004
Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemicsSally Blower, Anna Wald, Hayley Gershengorn, et al.Journal of Medical Virology|May 20, 2005
Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assayLawrence Corey, Meei-Li Huang, Stacy Selke, et al.Open Forum Infectious Diseases|July 15, 2020
An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2Joshua T Schiffer, Christine Johnston, Anna Wald, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2004
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemicsLawrence Corey, Anna Wald, Connie L Celum, et al.Sexually Transmitted Diseases|February 5, 2003
Natural history of genital herpes simplex virus type 1 infectionRebecca Engelberg, David Carrell, Elizabeth Krantz, et al.Antimicrobial Agents and Chemotherapy|September 11, 2013
Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agentsJoshua T Schiffer, David A Swan, Lawrence Corey, et al.The Journal of Infectious Diseases|July 28, 2011
The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactionsJoshua T Schiffer, Anna Wald, Stacy Selke, et al.The Journal of Infectious Diseases|June 16, 2007
Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV diseaseVeronique Erard, Anna Wald, Lawrence Corey, et al.Pageof 102